
India’s Biocon posts higher quarterly profit on boost from generics, biosimilar business
Audio By Carbonatix BENGALURU/HYDERABAD (Reuters) -Indian biopharma firm Biocon’s profit more than doubled in the fourth quarter, led by strong demand for its generics and biosimilar drugs in its key U.S. and European markets. The company’s …